Skip to main content

Table 1 Comparing survival in days for patients with ovarian cancer categorized in different age groups and with high and low KIFC1 expression levels

From: KIFCI, a novel putative prognostic biomarker for ovarian adenocarcinomas: delineating protein interaction networks and signaling circuitries

Age groups (Years) Survival (days) for high KIFC1 expression Survival (days) for low KIFC1 expression
30-40 831.7 (N = 11) 1262.2 (N = 12)
40-50 916.2 (N = 57) 1100.2 (N = 54)
50-60 1025.1 (N = 89) 1147.3 (N = 103)
60-70 1239.4 (N = 61) 975.9 (N = 64)